What are the effects of the fifth revision of the Declaration of Helsinki?

BMJ (Clinical research ed.)

Volumn 323, Issue 7326, 2001, Pages 1417-1423

  Tollman, S M ^a   Bastian, H ^a   Doll, R ^a   Hirsch, L J ^a   Guess, H A ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CONTROLLED CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG INDUSTRY; HUMAN; HUMAN EXPERIMENT; INTERNATIONAL COOPERATION; MEDICAL ETHICS; PATIENT ADVOCACY; RESEARCH; REVIEW; STANDARD; VULNERABLE POPULATION; WORLD MEDICAL ASSOCIATION;

BIOMEDICAL AND BEHAVIORAL RESEARCH; WORLD MEDICAL ASSOCIATION;

CONTROLLED CLINICAL TRIALS; DEVELOPING COUNTRIES; DRUG INDUSTRY; HELSINKI DECLARATION; HUMAN EXPERIMENTATION; HUMANS; INTERNATIONALITY; PATIENT ADVOCACY; PLACEBOS; RESEARCH; VULNERABLE POPULATIONS;

EID: 0035893302     PISSN: 09598138     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.323.7326.1417     Document Type: Review

References (44)